No name. No product. No confirmed funding. And, possibly, a $2bn price tag. That is the shape of the newest bet in AI drug discovery. Miles Wang, a researcher at OpenAI, is leaving to start his own company, TechCrunch reported. He is in talks to raise about $200m at a $2bn valuation, with Lightspeed in […]<br /> This story continues at The Next Web [...]
Microsoft and OpenAI on Monday announced a sweeping overhaul of the partnership that has defined the commercial AI era, dismantling key pillars of exclusivity and revenue-sharing that bound the two co [...]
OpenAI on Thursday launched GPT-5.3-Codex-Spark, a stripped-down coding model engineered for near-instantaneous response times, marking the company's first significant inference partnership outsi [...]
Earlier today, OpenAI launched GPT-5.6-Cyber, a specialized model designed to perform advanced vulnerability research and exploit development for approved defenders — including categories of work th [...]
OpenAI on Wednesday launched GPT-Live, a pair of new voice models that fundamentally redesign how people talk to ChatGPT — replacing the company's existing Advanced Voice Mode with an architect [...]
Four supply-chain incidents hit OpenAI, Anthropic and Meta in 50 days: three adversary-driven attacks and one self-inflicted packaging failure. None targeted the model, and all four exposed the same g [...]
OpenAI on Monday launched a set of interactive visual tools inside ChatGPT that let users manipulate mathematical and scientific formulas in real time — a genuinely impressive education feature that [...]
OpenAI on Wednesday released GPT-5.3-Codex, which the company calls its most capable coding agent to date, in an announcement timed to land at the exact same moment Anthropic unveiled its own flagship [...]
Market researchers have embraced artificial intelligence at a staggering pace, with 98% of professionals now incorporating AI tools into their work and 72% using them daily or more frequently, accordi [...]